Key facts
- It has raised $500K; the latest was Later Stage VC in Sep 2025.
- Notable investors include Plug and Play Tech Center, Y Combinator, US National Science Foundation, Pioneer Fund, Climate Capital — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Birch Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Birch Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Birch Biosciences
Developer of a proprietary platform designed to engineer enzymes to offer a sustainable and cost-effective plastic recycling process. The company's platform leverages artificial intelligence, bioinformatics and screening techniques to engineer enzymes and naturally break down plastic, enabling companies with quality, environmentally sustainable and cost-competitive recycled outputs.
- Sector
- Information Technology
- HQ
- Portland, OR, United States
- Founded
- 2021
- Employees
- 8
- Website
- birchbiosciences.com/
- Ownership
- Privately Held (backing)
Birch Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Birch Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Birch Biosciences in its N-PORT filings yet. We sweep new filings monthly.